Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function.

Area of Science:

• Immunology
• Epigenetics
• Cellular Biology

Background:

• Neonates typically exhibit Th2-biased immune responses, but the underlying molecular mechanisms remain unclear.
• Understanding these mechanisms is crucial for addressing immune development and function in early life.

Purpose of the Study:

• To investigate the cell-intrinsic molecular basis for rapid Th2 immune responses in neonatal T cells.
• To identify epigenetic factors contributing to the Th2 bias in neonatal immunity.

Main Methods:

• Analysis of cytokine production (IL-4, IL-13) in activated neonatal CD4(+) T cells.
• CpG methylation analysis of the conserved noncoding sequence 1 (CNS-1) regulatory region.
• Assessment of STAT6 dependency and developmental timing of epigenetic modifications.

Main Results:

• Neonatal CD4(+) T cells rapidly produced high levels of IL-4 and IL-13 post-activation.
• Pre-existing hypomethylation at the CNS-1 region was identified in resting neonatal cells.
• CNS-1 hypomethylation was established early in thymocyte development and was independent of STAT6.

Conclusions:

• Neonatal CD4(+) T cells possess intrinsic epigenetic properties, specifically CNS-1 hypomethylation, predisposing them to rapid Th2 effector function.
• This epigenetic state contributes to the characteristic Th2-biased immune responses observed in neonates.